T
Trajan
Biotech & Life Sciences · Melbourne, Australia · Founded 2011 · IPO 2021 Thoroughbred
Develops and commercializes technologies related to analytical systems for biological, environmental, and food related measurements
Global footprint
Where Trajan has talent and traffic
team presence
across markets
Capital deployed
Trajan's 3 investments and acquisitions.
Every disclosed deal where Trajan appeared as a backer or acquirer, 2021–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Trajan's capital deployment.
Where the deals concentrate by sector, stage, and decade.
01 · Portfolio market map
Trajan's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Sentiment on X
What X is saying about Trajan
An AI-synthesized read of the highest-engagement posts about Trajan on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Trajan on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.